CGTX
Cognition Therapeutics Inc
0.96$
+0.6%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -0.14 | -0.16 | -0.16 | -0.64 | -0.53 | -0.72 | -0.34 | |
| 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 | |
| 0.00 | 0.02 | 0.23 | 0.12 | 0.14 | 0.09 | 0.03 | |
| 0.03 | 0.02 | 0.21 | 0.12 | – | – | – | |
| 0.03 | 0.14 | 0.13 | -0.03 | 0.16 | 0.03 | -0.05 | |
| 0.01 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | |
| -0.01 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 | |
| – | – | – | 0.24 | – | – | – | |
| 0.13 | 0.26 | -0.01 | -0.05 | -0.03 | -0.02 | 0.00 | |
| 0.13 | 0.26 | 2.39 | 0.19 | 0.15 | 0.59 | 0.50 | |
| -0.02 | 0.10 | 2.23 | -0.45 | -0.39 | -0.12 | 0.16 | |
| -0.15 | -0.16 | -0.16 | -0.65 | -0.54 | -0.72 | -0.34 |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.